Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial

Ketty Peris; E Campione; T Micantonio; Gc Marulli; Mc Fargnoli; S. Chimenti

Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial

Ketty Peris
, E Campione
, T Micantonio
, Gc Marulli
, Mc Fargnoli
, S. Chimenti

Risultato della ricerca: Contributo in rivista › Articolo

66 Citazioni (Scopus)

Abstract

Imiquimod is an immune response modifier shown to be effective in basal cell carcinoma (BCC).

Lingua originale	Inglese
pagine (da-a)	318-323
Numero di pagine	6
Rivista	Dermatologic Surgery
Volume	31
Stato di pubblicazione	Pubblicato - 2005

Keywords

Adjuvants, Immunologic
Aged
Aged, 80 and over
Aminoquinolines
Antineoplastic Agents
Carcinoma, Basal Cell
Female
Humans
Male
Middle Aged
Skin Neoplasms
Treatment Outcome

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{0fc4e726430645d8aa8ff61e7f8b2ee5,

title = "Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial",

abstract = "Imiquimod is an immune response modifier shown to be effective in basal cell carcinoma (BCC).",

keywords = "Adjuvants, Immunologic, Aged, Aged, 80 and over, Aminoquinolines, Antineoplastic Agents, Carcinoma, Basal Cell, Female, Humans, Male, Middle Aged, Skin Neoplasms, Treatment Outcome, Adjuvants, Immunologic, Aged, Aged, 80 and over, Aminoquinolines, Antineoplastic Agents, Carcinoma, Basal Cell, Female, Humans, Male, Middle Aged, Skin Neoplasms, Treatment Outcome",

author = "Ketty Peris and E Campione and T Micantonio and Gc Marulli and Mc Fargnoli and S. Chimenti",

year = "2005",

language = "English",

volume = "31",

pages = "318--323",

journal = "Dermatologic Surgery",

issn = "1076-0512",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial

AU - Peris, Ketty

AU - Campione, E

AU - Micantonio, T

AU - Marulli, Gc

AU - Fargnoli, Mc

AU - Chimenti, S.

PY - 2005

Y1 - 2005

N2 - Imiquimod is an immune response modifier shown to be effective in basal cell carcinoma (BCC).

AB - Imiquimod is an immune response modifier shown to be effective in basal cell carcinoma (BCC).

KW - Adjuvants, Immunologic

KW - Aged

KW - Aged, 80 and over

KW - Aminoquinolines

KW - Antineoplastic Agents

KW - Carcinoma, Basal Cell

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Skin Neoplasms

KW - Treatment Outcome

KW - Adjuvants, Immunologic

KW - Aged

KW - Aged, 80 and over

KW - Aminoquinolines

KW - Antineoplastic Agents

KW - Carcinoma, Basal Cell

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Skin Neoplasms

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/57646

M3 - Article

SN - 1076-0512

VL - 31

SP - 318

EP - 323

JO - Dermatologic Surgery

JF - Dermatologic Surgery

ER -

Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial

Abstract

Keywords

Altri file e collegamenti

Fingerprint

Cita questo